荷爾蒙補充療法市場規模、佔有率、成長分析、按治療類型、按適應症、按地區 - 產業預測，2025-2032 年

Hormone Replacement Therapy Market Size, Share, Growth Analysis, By Therapy Type, By Indication, By Region - Industry Forecast 2025-2032

出版日期: 2024年12月25日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

荷爾蒙補充療法（HRT）的全球市場規模在2023年估值為289.7億美元，從2024年的312.3億美元成長到2032年的563.5億美元，在預測期內（2025年）預計年複合成長率為2032 年為7.8%）。

荷爾蒙補充療法（HRT）市場正在經歷顯著成長，主要是由於其在治療潮熱和骨質疏鬆症風險等更年期相關症狀方面的長期有效性。人們對影響包括男性在內的不同年齡層的其他荷爾蒙相關疾病的認知不斷提高和患病率的提高進一步推動了這一市場的擴張。甲狀腺疾病的激增也促進了市場的成長，美國甲狀腺協會報告稱，12% 的美國人一生中會患上甲狀腺疾病。長效人體生長荷爾蒙(hGH) 產品增加了治療選擇，最近的研究表明 HRT 可能會降低 COVID-19 感染和死亡的風險。因此，HRT 市場預計將在預測期內強勁擴張。

The hormone replacement therapy (HRT) market is witnessing significant growth, primarily due to its longstanding effectiveness in treating menopause-related symptoms such as hot flashes and osteoporosis risks. This expansion is further fueled by increasing awareness and prevalence of other hormone-related conditions affecting diverse age groups, including men. The surge in thyroid disorders, with the American Thyroid Association reporting that 12% of Americans will experience thyroid disease in their lifetime, is also contributing to market growth. Long-acting human growth hormone (hGH) products are enhancing treatment options, while recent studies suggest HRT may lower the risk of COVID-19 infection and mortality. Consequently, the HRT market is poised for robust expansion during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hormone Replacement Therapy (Hrt) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hormone Replacement Therapy (Hrt) Market Segmental Analysis

Global Hormone Replacement Therapy (HRT) Market is segmented by therapy type, indication, route of administration, distribution channel and region. Based on therapy type, the market is segmented into estrogen and combinations replacement therapy, thyroid hormone replacement therapy, growth hormone replacement therapy and testosterone hormone replacement therapy. Based on indication, the market is segmented into menopause, hypothyroidism, male hypogonadism and growth hormone deficiency. Based on route of administration, the market is segmented into oral, transdermal and parenteral. Based on distribution channel, the market is segmented into hospitals pharmacies, retail pharmacies & drug stores and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hormone Replacement Therapy (Hrt) Market

The global Hormone Replacement Therapy (HRT) market is driven by a pressing need for effective treatments among diverse patient groups, including those facing growth hormone deficiencies, menopausal symptoms in women, and hypogonadism in older men. This medication is available in various forms such as skin and buccal patches, injections, and tablets, which enhances accessibility for patients. As demand surges worldwide, manufacturers are prioritizing the development of innovative drug delivery systems, including transdermal estrogen patches and vaginal estrogen tablets. In response to safety concerns, there is a growing emphasis on low-dose estrogen therapy, alongside new gel-based formulations for estrogen patches and other delivery methods.

Restraints in the Global Hormone Replacement Therapy (Hrt) Market

The Global Hormone Replacement Therapy (HRT) market faces several restraints that may hinder its growth. Various treatment formulations, including patches, gels, capsules, and injections, are available; however, their potential side effects can be a significant deterrent. Issues such as elevated cholesterol levels, blood clots, bloating, and swelling can negatively impact patient perception and adoption. Furthermore, testosterone replacement therapy has been linked to adverse effects including benign prostatic hyperplasia, obstructive sleep apnea, and an increased risk of prostate cancer. The US FDA's concerns regarding the approved indications and the rising cardiovascular risks associated with testosterone products add another layer of complication that may impede market expansion.

Market Trends of the Global Hormone Replacement Therapy (Hrt) Market

The Global Hormone Replacement Therapy (HRT) market is witnessing a significant upward trend, fueled by rising demand in emerging nations and heightened awareness of hormone-related health issues. As more individuals recognize the benefits of HRT, pharmaceutical companies are innovating to develop advanced medications that cater to this unmet need. Notably, the aging population and increasing prevalence of menopause and associated hormone deficiencies in key markets are driving manufacturers to unveil novel product offerings, including combination therapies that enhance efficacy and patient compliance, moving away from traditional long-acting parenteral options. This evolution underscores the dynamic nature of the HRT sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Case Study Analysis
Patent Analysis

Global Hormone Replacement Therapy (HRT) Market Size by Therapy Type & CAGR (2025-2032)

Market Overview
Estrogen and Combinations Replacement Therapy
Thyroid Hormone Replacement Therapy
Growth Hormone Replacement Therapy
Testosterone Hormone Replacement Therapy

Global Hormone Replacement Therapy (HRT) Market Size by Indication & CAGR (2025-2032)

Market Overview
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency

Global Hormone Replacement Therapy (HRT) Market Size by Route Of Administration & CAGR (2025-2032)

Market Overview
Oral
Transdermal
Parenteral

Global Hormone Replacement Therapy (HRT) Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospitals Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies

Global Hormone Replacement Therapy (HRT) Market Size & CAGR (2025-2032)

North America (Therapy Type, Indication, Route Of Administration, Distribution Channel)
- US
- Canada
Europe (Therapy Type, Indication, Route Of Administration, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Therapy Type, Indication, Route Of Administration, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Therapy Type, Indication, Route Of Administration, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Therapy Type, Indication, Route Of Administration, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TherapeuticsMD Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (now part of Viatris)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (now part of AbbVie)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ipsen S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (GSK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments